Enanta Pharmaceuticals, Inc. (ENTA)

NMS – Real Time Price. Currency in USD

13.51

-0.01 (-0.07%)

Market open: Aug 12, 2026, 12:25 PM EDT

13.52

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

65M

68M

79M

86M

Cost of goods sold

-5M

-2M

-3M

Gross Profit

61M

65M

77M

83M

Operating expenses (excl. COGS)

-146M

-187M

-214M

-207M

Operating Income

-85M

-122M

-137M

-124M

Non-operating income, total

Pretax income

-84M

-118M

-131M

-122M

Equity in earnings

Taxes

-3M

433K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-82M

-116M

-134M

-122M

Discontinued operations

Net income

-82M

-116M

-134M

-122M

Dilution adjustment

Preferred dividends

Enanta Pharmaceuticals, Inc. (ENTA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Enanta Pharmaceuticals, Inc. (ENTA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Enanta Pharmaceuticals, Inc. (ENTA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Enanta Pharmaceuticals, Inc. (ENTA)

Income Statement (Annual)

Income Statement (Annual)